John Wesson Ashford
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John Wesson Ashford has a total of 166 co-authors. Here are the top co-authors by number of shared publications:
Curtis B. Ashford
5 shared publicationsMichael F. Bergeron
Department of Health Sciences, University of Hartford, West Hartford, USA
5 shared publicationsPeter J. Bayley
VA Palo Alto Health Care System, Palo Alto, CA, United States
5 shared publicationsJames O. Clifford
3 shared publicationsKerry L. Coburn
Department of Psychiatry and Behavioral Sciences, Mercer University School of Medicine, GA, USA
3 shared publicationsSulekha Anand
3 shared publications
Latest Publications
- Open Access
- 20 April 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Subjective Concerns about Cognitive Decline and Objective Measures of Cognition Assessed by a Continuous Recognition Task (MemTrax): Changes in Adult Males and Females over the Lifespan (Preprint)
BACKGROUND Adults may experience subjective cognitive decline (SCD). However, it is unclear whether SCD is related to measurable cognitive impairment, particularly women ages 40 to 60 and early dementia. Further, Medicare has mandated assessment of cognitive and memory function in individuals over 65 as part of the Medicare Annual Wellness Visit. In order to assess possible impairment and change over time, efficient, objective measures of SCD are needed. OBJECTIVE To assess the relationship between performance on an online continuous recognition task (CRT, MemTrax) and age, sex, and memory concern. METHODS This study evaluated CRT performance in participants aged 21-99 who enrolled in an online program (HAPPYneuron) to measure mental functions, including those who reported concerns about them. This program asked participants if they had complaints about their memory, and then the program offered them the opportunity to assess cognition using the CRT. This CRT instructs individuals to attend to visual stimuli (50 images) and respond as quickly as possible to repeated images (25 images). The CRT components were used to measure learning and memory (as related to HITs, response to a repeated image), executive function (as related to CRs, correctly not responding to an initial image presentation), and processing speed (HIT-RTs, average response time to HITs). RESULTS Analysis of 18,178 (5,795 males, 32%; 12,383 females, 68%) only included those who answered the sex, age, and memory questions. There were 11,786 (65%) between 40 and 70 years of age. Females outnumbered males by over two-fold, beginning about 35 years of age, peaking at 55 years of age at over three-fold, and falling below two-fold at about 65 years of age. Approximately 30% more men complained of memory problems than those who did not, primarily 30 – 60 years old. About 80% more women complained of memory problems, over two-fold more than women who did not, 30-50 years old. The number of HITs, number of CRs, and HIT-RTs varied little between men and women. While those without memory complaints generally performed better than those with memory complaints, there was little difference in performance levels for each group between males and females. For all groups, there was a gradual reduction of performance over age for HITs and CRs and a slowing of HIT-RTs. CONCLUSIONS Most subjects were 40-65, more than twice as many females, suggesting that these demographics have a relationship to concern about SCD. However, there was little difference between males and females for the various CRT components, though SCD was associated with impairment. Age-related declines were progressive, the largest being in slower processing speed, presumably to compensate for age-related changes in cognitive function. Present results suggest clinicians may use these metrics to quantify patient concerns expressed in the primary care setting. CLINICALTRIAL none
- 20 April 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessSubjective Concerns about Cognitive Decline and Objective Measures of Cognition Assessed by a Continuous Recognition Task (MemTrax): Changes in Adult Males and Females over the Lifespan (Preprint)
BACKGROUND Adults may experience subjective cognitive decline (SCD). However, it is unclear whether SCD is related to measurable cognitive impairment, particularly women ages 40 to 60 and early dementia. Further, Medicare has mandated assessment of cognitive and memory function in individuals over 65 as part of the Medicare Annual Wellness Visit. In order to assess possible impairment and change over time, efficient, objective measures of SCD are needed. OBJECTIVE To assess the relationship between performance on an online continuous recognition task (CRT, MemTrax) and age, sex, and memory concern. METHODS This study evaluated CRT performance in participants aged 21-99 who enrolled in an online program (HAPPYneuron) to measure mental functions, including those who reported concerns about them. This program asked participants if they had complaints about their memory, and then the program offered them the opportunity to assess cognition using the CRT. This CRT instructs individuals to attend to visual stimuli (50 images) and respond as quickly as possible to repeated images (25 images). The CRT components were used to measure learning and memory (as related to HITs, response to a repeated image), executive function (as related to CRs, correctly not responding to an initial image presentation), and processing speed (HIT-RTs, average response time to HITs). RESULTS Analysis of 18,178 (5,795 males, 32%; 12,383 females, 68%) only included those who answered the sex, age, and memory questions. There were 11,786 (65%) between 40 and 70 years of age. Females outnumbered males by over two-fold, beginning about 35 years of age, peaking at 55 years of age at over three-fold, and falling below two-fold at about 65 years of age. Approximately 30% more men complained of memory problems than those who did not, primarily 30 – 60 years old. About 80% more women complained of memory problems, over two-fold more than women who did not, 30-50 years old. The number of HITs, number of CRs, and HIT-RTs varied little between men and women. While those without memory complaints generally performed better than those with memory complaints, there was little difference in performance levels for each group between males and females. For all groups, there was a gradual reduction of performance over age for HITs and CRs and a slowing of HIT-RTs. CONCLUSIONS Most subjects were 40-65, more than twice as many females, suggesting that these demographics have a relationship to concern about SCD. However, there was little difference between males and females for the various CRT components, though SCD was associated with impairment. Age-related declines were progressive, the largest being in slower processing speed, presumably to compensate for age-related changes in cognitive function. Present results suggest clinicians may use these metrics to quantify patient concerns expressed in the primary care setting. CLINICALTRIAL none
- 4 December 2025
- Published by Springer Nature
- p. 1-27
Putative Survival Advantages in Infant, Child, and Young Adult Apolipoprotein ε4 Carriers
- 4 December 2025
- Published by Springer Nature
- p. 1-27
Putative Survival Advantages in Infant, Child, and Young Adult Apolipoprotein ε4 Carriers
- Open Access
- 5 July 2025
- Published by Springer Nature in Alzheimer's Research & Therapy
- Vol. 17 (1) , 1-13
Predicting brain amyloid load with digital and blood-based biomarkers
Background: With the recent approval of anti-β-amyloid (Aβ) treatment for Alzheimer’s disease (AD), a demand has emerged for scalable, convenient and accurate estimations of brain Aβ burden for the detection of AD that would enable timely, accurate and reliable diagnosis in one’s primary care physician’s (PCPs) office as called for recently by World Health Organization (WHO). Methods: MemTrax, a 2-minute online memory test, was selected as the digital biomarker of cognitive impairment, and blood-based biomarkers (BBMs) including Aβ42, Aβ40, P-tau181, GFAP and NfL were used to estimate AD-related metrics in different groups of elderly individuals (n = 349) for comparison with Aβ PET scans of brain Aβ burden. The correlations between MemTrax, MoCA, BBMs and brain Aβ burden, expressed in centiloid (CL) values, were analyzed for predicting CL value alone or in combinations using machine-learning (ML). Results: Both MemTrax and the MoCA were able to differentiate Aβ status similarly. Integration of MemTrax and BBMs using ML, however, significantly improved the AUCs (over the same with MoCA) for differentiating Aβ status. MemTrax and p-Tau181/Aβ42 composite showed the strongest relationship with CL value among other BBMs. Most importantly, regression analyses of MemTrax and p-Tau181/Aβ42 aptly predicted CL values. Conclusion: The combination of MemTrax and BBMs provides an accurate, convenient, non-invasive, cost-effective and scalable way to estimate Aβ load, which provides an opportunity for mass screening and timely and accurate diagnosis of AD. Our findings could also facilitate more effective AD clinical management in the PCPs office worldwide for more equitable access to current standard of care.
- 5 July 2025
- Published by Springer Nature in Alzheimer's Research & Therapy
- Vol. 17 (1) , 1-13
Open AccessPredicting brain amyloid load with digital and blood-based biomarkers
Background: With the recent approval of anti-β-amyloid (Aβ) treatment for Alzheimer’s disease (AD), a demand has emerged for scalable, convenient and accurate estimations of brain Aβ burden for the detection of AD that would enable timely, accurate and reliable diagnosis in one’s primary care physician’s (PCPs) office as called for recently by World Health Organization (WHO). Methods: MemTrax, a 2-minute online memory test, was selected as the digital biomarker of cognitive impairment, and blood-based biomarkers (BBMs) including Aβ42, Aβ40, P-tau181, GFAP and NfL were used to estimate AD-related metrics in different groups of elderly individuals (n = 349) for comparison with Aβ PET scans of brain Aβ burden. The correlations between MemTrax, MoCA, BBMs and brain Aβ burden, expressed in centiloid (CL) values, were analyzed for predicting CL value alone or in combinations using machine-learning (ML). Results: Both MemTrax and the MoCA were able to differentiate Aβ status similarly. Integration of MemTrax and BBMs using ML, however, significantly improved the AUCs (over the same with MoCA) for differentiating Aβ status. MemTrax and p-Tau181/Aβ42 composite showed the strongest relationship with CL value among other BBMs. Most importantly, regression analyses of MemTrax and p-Tau181/Aβ42 aptly predicted CL values. Conclusion: The combination of MemTrax and BBMs provides an accurate, convenient, non-invasive, cost-effective and scalable way to estimate Aβ load, which provides an opportunity for mass screening and timely and accurate diagnosis of AD. Our findings could also facilitate more effective AD clinical management in the PCPs office worldwide for more equitable access to current standard of care.
- Open Access
- 3 June 2025
- Published by AccScience Publishing in Gene & Protein in Disease
- Vol. 4 (4) , 6557
Exploring dopamine as the master regulator of brain circuitry and mental health genome
Artificially increasing dopamine transmission is the common mechanism by which substances with addictive potential lead to addiction. A key area of research in neurobiology is the role of dopamine. Significant advancements have been made in uncovering the intracellular signaling pathways that mediate both dopamine’s immediate effects and its long-term influence on brain function. Recent discoveries have also highlighted specific molecules that could serve as potential therapeutic targets for neurological and psychiatric disorders. While understanding several important caveats, we believe dopamine acts as a master regulator of brain circuitry across major chromosomes mapping the mental health genome. This view may have important clinical relevance, emphasizing the critical role of dopaminergic activity across the genome. Importantly, we are cognizant that dopamine does not work in insolation, and its finite actions are due to a highly interactive network (known as the brain reward cascade), involving at least seven other major neurotransmitters.
- 3 June 2025
- Published by AccScience Publishing in Gene & Protein in Disease
- Vol. 4 (4) , 6557
Open AccessExploring dopamine as the master regulator of brain circuitry and mental health genome
Artificially increasing dopamine transmission is the common mechanism by which substances with addictive potential lead to addiction. A key area of research in neurobiology is the role of dopamine. Significant advancements have been made in uncovering the intracellular signaling pathways that mediate both dopamine’s immediate effects and its long-term influence on brain function. Recent discoveries have also highlighted specific molecules that could serve as potential therapeutic targets for neurological and psychiatric disorders. While understanding several important caveats, we believe dopamine acts as a master regulator of brain circuitry across major chromosomes mapping the mental health genome. This view may have important clinical relevance, emphasizing the critical role of dopaminergic activity across the genome. Importantly, we are cognizant that dopamine does not work in insolation, and its finite actions are due to a highly interactive network (known as the brain reward cascade), involving at least seven other major neurotransmitters.
- 13 May 2025
- Published by Springer Nature
- p. 1-31
Apolipoprotein E4 Carriers as Clinical Trial Subjects
- 26 January 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 104 (1) , 32-35
The VA Million Veteran Program, Alzheimer's disease, and genetics: Important steps forward but many steps still to go on the march to control dementia and Alzheimer's disease
The VA Million Veteran Program (MVP) is a nationwide initiative that seeks to examine how genes influence health and behaviors in military veterans. An article by Merritt et al. analyzing data from the MVP, developing and testing algorithms to query dementia and Alzheimer's disease (AD) diagnoses from the VA's electronic health record system and examining genetic factors, provides an extraordinarily important contribution to the dementia and AD fields. The analyses presented in the article show how large databases can be used to further understand dementia and AD, pointing the way for many more important advances for this field.
- 26 January 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 104 (1) , 32-35
The VA Million Veteran Program, Alzheimer's disease, and genetics: Important steps forward but many steps still to go on the march to control dementia and Alzheimer's disease
The VA Million Veteran Program (MVP) is a nationwide initiative that seeks to examine how genes influence health and behaviors in military veterans. An article by Merritt et al. analyzing data from the MVP, developing and testing algorithms to query dementia and Alzheimer's disease (AD) diagnoses from the VA's electronic health record system and examining genetic factors, provides an extraordinarily important contribution to the dementia and AD fields. The analyses presented in the article show how large databases can be used to further understand dementia and AD, pointing the way for many more important advances for this field.
- 18 June 2024
- Published by Elsevier in Women's Health Issues
- Vol. 34 (4) , 325-330
A Multipronged Approach to Caring for Women Veterans With Military Environmental Exposures
- 18 June 2024
- Published by Elsevier in Women's Health Issues
- Vol. 34 (4) , 325-330
A Multipronged Approach to Caring for Women Veterans With Military Environmental Exposures
- Open Access
- 4 April 2024
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 18, 1304221
Episodic memory assessment: effects of sex and age on performance and response time during a continuous recognition task
Introduction: Continuous recognition tasks (CRTs) assess episodic memory (EM), the central functional disturbance in Alzheimer’s disease and several related disorders. The online MemTrax computerized CRT provides a platform for screening and assessment that is engaging and can be repeated frequently. MemTrax presents complex visual stimuli, which require complex involvement of the lateral and medial temporal lobes and can be completed in less than 2 min. Results include number of correct recognitions (HITs), recognition failures (MISSes = 1-HITs), correct rejections (CRs), false alarms (FAs = 1-CRs), total correct (TC = HITs + CRs), and response times (RTs) for each HIT and FA. Prior analyses of MemTrax CRT data show no effects of sex but an effect of age on performance. The number of HITs corresponds to faster RT-HITs more closely than TC, and CRs do not relate to RT-HITs. RT-HITs show a typical skewed distribution, and cumulative RT-HITs fit a negative survival curve (RevEx). Thus, this study aimed to define precisely the effects of sex and age on HITS, CRs, RT-HITs, and the dynamics of RTs in an engaged population.Methods: MemTrax CRT online data on 18,255 individuals was analyzed for sex, age, and distributions of HITs, CRs, MISSes, FAs, TC, and relationships to both RT-HITs and RT-FAs.Results: HITs corresponded more closely to RT-HITs than did TC because CRs did not relate to RT-HITs. RT-FAs had a broader distribution than RT-HITs and were faster than RT-HITs in about half of the sample, slower in the other half. Performance metrics for men and women were the same. HITs declined with age as RT-HITs increased. CRs also decreased with age and RT-FAs increased, but with no correlation. The group over aged 50 years had RT-HITs distributions slower than under 50 years. For both age ranges, the RevEx model explained more than 99% of the variance in RT-HITs.Discussion: The dichotomy of HITs and CRs suggests opposing cognitive strategies: (1) less certainty about recognitions, in association with slower RT-HITs and lower HIT percentages suggests recognition difficulty, leading to more MISSes, and (2) decreased CRs (more FAs) but faster RTs to HITs and FAs, suggesting overly quick decisions leading to errors. MemTrax CRT performance provides an indication of EM (HITs and RT-HITs may relate to function of the temporal lobe), executive function (FAs may relate to function of the frontal lobe), processing speed (RTs), cognitive ability, and age-related changes. This CRT provides potential clinical screening utility for early Alzheimer’s disease and other conditions affecting EM, other cognitive functions, and more accurate impairment assessment to track changes over time.
- 4 April 2024
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 18, 1304221
Open AccessEpisodic memory assessment: effects of sex and age on performance and response time during a continuous recognition task
Introduction: Continuous recognition tasks (CRTs) assess episodic memory (EM), the central functional disturbance in Alzheimer’s disease and several related disorders. The online MemTrax computerized CRT provides a platform for screening and assessment that is engaging and can be repeated frequently. MemTrax presents complex visual stimuli, which require complex involvement of the lateral and medial temporal lobes and can be completed in less than 2 min. Results include number of correct recognitions (HITs), recognition failures (MISSes = 1-HITs), correct rejections (CRs), false alarms (FAs = 1-CRs), total correct (TC = HITs + CRs), and response times (RTs) for each HIT and FA. Prior analyses of MemTrax CRT data show no effects of sex but an effect of age on performance. The number of HITs corresponds to faster RT-HITs more closely than TC, and CRs do not relate to RT-HITs. RT-HITs show a typical skewed distribution, and cumulative RT-HITs fit a negative survival curve (RevEx). Thus, this study aimed to define precisely the effects of sex and age on HITS, CRs, RT-HITs, and the dynamics of RTs in an engaged population.Methods: MemTrax CRT online data on 18,255 individuals was analyzed for sex, age, and distributions of HITs, CRs, MISSes, FAs, TC, and relationships to both RT-HITs and RT-FAs.Results: HITs corresponded more closely to RT-HITs than did TC because CRs did not relate to RT-HITs. RT-FAs had a broader distribution than RT-HITs and were faster than RT-HITs in about half of the sample, slower in the other half. Performance metrics for men and women were the same. HITs declined with age as RT-HITs increased. CRs also decreased with age and RT-FAs increased, but with no correlation. The group over aged 50 years had RT-HITs distributions slower than under 50 years. For both age ranges, the RevEx model explained more than 99% of the variance in RT-HITs.Discussion: The dichotomy of HITs and CRs suggests opposing cognitive strategies: (1) less certainty about recognitions, in association with slower RT-HITs and lower HIT percentages suggests recognition difficulty, leading to more MISSes, and (2) decreased CRs (more FAs) but faster RTs to HITs and FAs, suggesting overly quick decisions leading to errors. MemTrax CRT performance provides an indication of EM (HITs and RT-HITs may relate to function of the temporal lobe), executive function (FAs may relate to function of the frontal lobe), processing speed (RTs), cognitive ability, and age-related changes. This CRT provides potential clinical screening utility for early Alzheimer’s disease and other conditions affecting EM, other cognitive functions, and more accurate impairment assessment to track changes over time.
- 1 February 2024
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 120, 106016
The MemTrax memory test for detecting and assessing cognitive impairment in Parkinson's disease
- 1 February 2024
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 120, 106016
The MemTrax memory test for detecting and assessing cognitive impairment in Parkinson's disease
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S24)
Brief Continuous Recognition Task for Early Alzheimer Detection and Tracking
Background: Alzheimer’s Disease (AD) affects memory processing in the brain. An important aspect of AD assessment and study is memory testing, which can be done with excellent efficiency using a Continuous Recognition Test (CRT). A CRT was designed for online administration to provide 25 unique, complex, interesting images, which were initially presented for up to 3 seconds, and 25 repeated images, which required a response to indicate recognition (takes about 90 seconds). The images include 5 from each of 5 categories, from a set of 3,000 images, ensuring that a broad spectrum of memory is interrogated. The selected images are culturally neutral, and the instructions are provided in 120 languages, so the test is comparable across most countries, and performance is not affected by racial, cultural, or ethnic variations. The test is engaging and has been taken by many individuals over 100 times and by several individuals over 1,000 times. Two studies have compared this test with the Montreal Cognitive Assessment (MoCA) (in China and Netherlands) and found that this test performed at least as well.Method: Data was examined from over a million CRT administrations from 3 sources: at the URL: www.memtrax.com, including over 18,000 unique users recruited by a French company (HAPPYneuron, INC), over 200,000 unique users from free access, and over 90,000 unique users from a free recruitment program (www.brainhealthregistry.org, part of the Alzheimer’s Disease Neuroimaging Initiative). Response time data was available for every image of each CRT, and the 3 populations were evaluated for HITs (correct recognitions), Correct Rejections (CRs, not responding to a new image), and response time to HITs (RT), including average RTs.Result: Analyses indicated that 97% of individuals, across sites who scored better than chance (65% correct), performed better than 80% correct. Percent HITs and CRs and RTs showed a dichotomy with HITs (recognitions) correlating with RT (an AD dysfunction), while a separate group had fewer correct rejections (response disinhibition) and RT inconsistency, presumably related to fronto‐temporal dementia (clinical observation). Statistical analysis provides precision of impairment estimation.Conclusion: A CRT can be used for early AD screening, memory assessment, and progression tracking.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S24)
Open AccessBrief Continuous Recognition Task for Early Alzheimer Detection and Tracking
Background: Alzheimer’s Disease (AD) affects memory processing in the brain. An important aspect of AD assessment and study is memory testing, which can be done with excellent efficiency using a Continuous Recognition Test (CRT). A CRT was designed for online administration to provide 25 unique, complex, interesting images, which were initially presented for up to 3 seconds, and 25 repeated images, which required a response to indicate recognition (takes about 90 seconds). The images include 5 from each of 5 categories, from a set of 3,000 images, ensuring that a broad spectrum of memory is interrogated. The selected images are culturally neutral, and the instructions are provided in 120 languages, so the test is comparable across most countries, and performance is not affected by racial, cultural, or ethnic variations. The test is engaging and has been taken by many individuals over 100 times and by several individuals over 1,000 times. Two studies have compared this test with the Montreal Cognitive Assessment (MoCA) (in China and Netherlands) and found that this test performed at least as well.Method: Data was examined from over a million CRT administrations from 3 sources: at the URL: www.memtrax.com, including over 18,000 unique users recruited by a French company (HAPPYneuron, INC), over 200,000 unique users from free access, and over 90,000 unique users from a free recruitment program (www.brainhealthregistry.org, part of the Alzheimer’s Disease Neuroimaging Initiative). Response time data was available for every image of each CRT, and the 3 populations were evaluated for HITs (correct recognitions), Correct Rejections (CRs, not responding to a new image), and response time to HITs (RT), including average RTs.Result: Analyses indicated that 97% of individuals, across sites who scored better than chance (65% correct), performed better than 80% correct. Percent HITs and CRs and RTs showed a dichotomy with HITs (recognitions) correlating with RT (an AD dysfunction), while a separate group had fewer correct rejections (response disinhibition) and RT inconsistency, presumably related to fronto‐temporal dementia (clinical observation). Statistical analysis provides precision of impairment estimation.Conclusion: A CRT can be used for early AD screening, memory assessment, and progression tracking.